X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
BlackRock, Inc. reported a 5.90% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 30, 2026
BlackRock, Inc. reported a 5.90% stake in X4 Pharmaceuticals, Inc., 5,529,573 shares, as a passive investor on Jun 30, 2026. Filed Jul 30, 2026 (Schedule 13G).
- Stake
- 5.90%
- Shares
- 5,529,573
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock, Inc. | 5.90% | 5,529,573 |
Source
Related
- X4 Pharmaceuticals, Inc.
- BlackRock, Inc.
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · BlackRock, Inc. · Jul 18, 2025
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026